TMC is a global clinical research organisation dedicated to supporting the progression of life-saving treatment solutions for diseases that are often neglected.
We’re a specialised and experienced full-service CRO providing world-class support to pharma/biotech companies. To maximise success, we offer our clients a broad range of services with a focused and tailored approach for all their drug development requirements.
Our Expertise
Our development support activities span the early pre-clinical phase right through to post-marketing. We provide all the functions of a fully resourced pharmaceutical company, providing ‘bolt-on’ services that complement a client’s in-house resource, enabling them to access all the development capability appropriate for each stage of their project.
Experienced
We only employ knowledgeable and trusted Associates who have worked in the pharma industry for at least 15 years. These experts can draw on their extensive experience to guide programmes and strategies — providing flexible, integrated and cost-effective solutions to meet our clients’ needs.
Focused
We specialise in orphan, rare and oncology diseases. Rare diseases affect 1 in 10 people, meaning more than 350 million people worldwide*. These people are often overlooked as there are significant challenges in the design and execution of clinical trials therapeutics. That’s why it’s our mission, indeed our passion, to offer drug development support in these disease areas.
*Source: https://www.rareundiagnosed.org/rare-disease-facts/
Tailored
No two drug development programmes are the same — just as no two patients are the same. We help our clients understand the patient journey, facilitating their drug development pathway to bring treatments to market quickly and efficiently.
Milestones in Numbers
Championing the patients living with life-limiting orphan and rare diseases